Skip to Main Content

464

Views

3

CrossRef citations to date

0

Altmetric

Original research

Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study

Franco Citterioa Department of Surgery, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, ItalyCorrespondence[email protected]
View further author information

,

Mitchell Henryb Department of Surgery, The Comprehensive Transplant Center, The Ohio State University, Wexner Medical Center, Columbus, OH, USAView further author information

,

Dean Y Kimc Department of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, USAView further author information

,

Myoung Soo Kimd Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of KoreaView further author information

,

Duck-Jong Hane Department of Surgery, Asan Medical Center, Seoul, Republic of South KoreaView further author information

,

Takashi Kenmochif Department of Transplant Surgery, Fujita Health University, Toyoake, JapanView further author information

,

Eytan Morg Department of Surgery, Transplant Center at Sheba Medical Center, Ramat-Gan, IsraelView further author information

,

Giuseppe Tisoneh Department of Surgery HPB and Transplant Unit, University of Tor Vergata, Rome, ItalyView further author information

,

Peter Bernhardti Department of Research and Development, Novartis Pharma AG, Basel, SwitzerlandView further author information

,

Maria Pilar Hernandez Gutierrezi Department of Research and Development, Novartis Pharma AG, Basel, SwitzerlandView further author information

&

Yoshihiko Wataraij Department of Transplant Surgery and Nephrology, Nagoya Daini Red Cross Hospital, Nagoya-City, JapanView further author information